# The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker

> **NCT02030418** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 952 (actual)

## Conditions studied

- Bradycardia

## Interventions

- **DEVICE:** Leadless Pacemaker

## Key facts

- **NCT ID:** NCT02030418
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-06
- **Final completion:** 2022-07-15
- **Target enrollment:** 952 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030418, "The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02030418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*